Predicting the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Soluble Immune Checkpoints.

Ari, Aziz; Sevik, Husnu; Sevinc, Mert Mahsuni; Tatar, Cihad; Buyukasik, Kenan; Surel, Aziz Ahmet; Idiz, Ufuk Oguz

Ari, Aziz; Sevik, Husnu; Sevinc, Mert Mahsuni; Tatar, Cihad; Buyukasik, Kenan; Surel, Aziz Ahmet; Idiz, Ufuk Oguz.

Afiliação

Ari A; Department of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey.
Sevik H; Department of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey.
Sevinc MM; Department of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey.
Tatar C; Department of General Surgery, Acibadem Taksim Hospital, Istanbul, Turkey.
Buyukasik K; Department of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey.
Surel AA; Department of General Surgery, Ankara Bilkent City Hospital, Cankaya, Turkey.
Idiz UO; Department of General Surgery, Istanbul Training and Research Hospital, Istanbul, Turkey.

Cancer Biother Radiopharm ; 39(3): 247-254, 2024 Apr.

Article em En | MEDLINE | ID: mdl-38010745

Assuntos

Neoplasias Retais; Reto; Humanos; Reto/patologia; Terapia Neoadjuvante/métodos; Resultado do Tratamento; Estudos Prospectivos; Quimiorradioterapia/métodos; Neoplasias Retais/terapia; Neoplasias Retais/patologia; Galectinas; Estudos Retrospectivos

Palavras-chave

galectin-9; neoadjuvant treatment; platelet; rectal cancer; soluble immune checkpoint

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Reto Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Reto Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article